Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Luteolin ameliorates dextran sulfate sodium-induced colitis in mice possibly through activation of the Nrf2 signaling pathway
Yue Li, Lei Shen, Hesheng Luo
International Immunopharmacology (2016) Vol. 40, pp. 24-31
Closed Access | Times Cited: 94

Showing 1-25 of 94 citing articles:

Recent Advances of Natural Polyphenols Activators for Keap1‐Nrf2 Signaling Pathway
Yanping Zhou, Zhongliang Jiang, Haiying Lu, et al.
Chemistry & Biodiversity (2019) Vol. 16, Iss. 11
Closed Access | Times Cited: 164
Luteolin alleviates inflammation and modulates gut microbiota in ulcerative colitis rats
Bolin Li, Pengli Du, Yao Du, et al.
Life Sciences (2021) Vol. 269, pp. 119008-119008
Open Access | Times Cited: 163
Lonicerin targets EZH2 to alleviate ulcerative colitis by autophagy-mediated NLRP3 inflammasome inactivation
Qi Lv, Xing Yao, Jian Liu, et al.
Acta Pharmaceutica Sinica B (2021) Vol. 11, Iss. 9, pp. 2880-2899
Open Access | Times Cited: 141
ROS-responsive nanoparticles for oral delivery of luteolin and targeted therapy of ulcerative colitis by regulating pathological microenvironment
Chen Tan, Heng Fan, Jiahui Ding, et al.
Materials Today Bio (2022) Vol. 14, pp. 100246-100246
Open Access | Times Cited: 70
Therapeutic potential of traditional Chinese medicine in the prevention and treatment of digestive inflammatory cancer transformation: Portulaca oleracea L. as a promising drug
Gaoxuan Shao, Ying Liu, Lu Lu, et al.
Journal of Ethnopharmacology (2024) Vol. 327, pp. 117999-117999
Open Access | Times Cited: 18
Thirty years of NRF2: advances and therapeutic challenges
Donna D. Zhang
Nature Reviews Drug Discovery (2025)
Closed Access | Times Cited: 3
Phytochemicals and inflammatory bowel disease: a review
Imam Hossen, Hua Wu, Luo Ting, et al.
Critical Reviews in Food Science and Nutrition (2019) Vol. 60, Iss. 8, pp. 1321-1345
Closed Access | Times Cited: 118
Luteolin prevents irinotecan‐induced intestinal mucositis in mice through antioxidant and anti‐inflammatory properties
Thaise Boeing, Priscila de Souza, Silvia Speca, et al.
British Journal of Pharmacology (2020) Vol. 177, Iss. 10, pp. 2393-2408
Open Access | Times Cited: 114
Astragalus membranaceus Extract Attenuates Inflammation and Oxidative Stress in Intestinal Epithelial Cells via NF-κB Activation and Nrf2 Response
Simona Adesso, Rosario Russo, Andrea Quaroni, et al.
International Journal of Molecular Sciences (2018) Vol. 19, Iss. 3, pp. 800-800
Open Access | Times Cited: 104
Maresin 1 alleviates dextran sulfate sodium-induced ulcerative colitis by regulating NRF2 and TLR4/NF-kB signaling pathway
Shujin Qiu, Ping Li, Hengfang Zhao, et al.
International Immunopharmacology (2019) Vol. 78, pp. 106018-106018
Closed Access | Times Cited: 99
Brassica-Derived Plant Bioactives as Modulators of Chemopreventive and Inflammatory Signaling Pathways
Christine Sturm, Anika E. Wagner
International Journal of Molecular Sciences (2017) Vol. 18, Iss. 9, pp. 1890-1890
Open Access | Times Cited: 98
Citrusfruits and their flavonoids in inflammatory bowel disease: an overview
Laura Musumeci, Alessandro Maugeri, Santa Cirmi, et al.
Natural Product Research (2019) Vol. 34, Iss. 1, pp. 122-136
Closed Access | Times Cited: 94
Natural Anti-Inflammatory Compounds as Drug Candidates for Inflammatory Bowel Disease
Linshan Duan, Shu-Yu Cheng, Long Li, et al.
Frontiers in Pharmacology (2021) Vol. 12
Open Access | Times Cited: 89
The role and mechanism of flavonoid herbal natural products in ulcerative colitis
Jia-Chen Xue, Shuo Yuan, Huan Meng, et al.
Biomedicine & Pharmacotherapy (2022) Vol. 158, pp. 114086-114086
Open Access | Times Cited: 63
Treatment Effects of Natural Products on Inflammatory Bowel Disease In Vivo and Their Mechanisms: Based on Animal Experiments
Yaxi Zhou, Diandian Wang, Wenjie Yan
Nutrients (2023) Vol. 15, Iss. 4, pp. 1031-1031
Open Access | Times Cited: 36
Inhibition of ferroptosis: A new direction in the treatment of ulcerative colitis by traditional Chinese medicine
Meitong Guo, Xingchen Du, Xiaoyan Wang
Journal of Ethnopharmacology (2024) Vol. 324, pp. 117787-117787
Open Access | Times Cited: 10
Luteolin Alleviates Ulcerative Colitis in Mice by Modulating Gut Microbiota and Plasma Metabolism
Shuai Yang, Hongwei Duan, Zhenxing Yan, et al.
Nutrients (2025) Vol. 17, Iss. 2, pp. 203-203
Open Access | Times Cited: 1
The NRF2 transcription factor plays a dual role in colorectal cancer: A systematic review
Carmen González-Donquiles, Jéssica Alonso-Molero, Tania Fernández‐Villa, et al.
PLoS ONE (2017) Vol. 12, Iss. 5, pp. e0177549-e0177549
Open Access | Times Cited: 72
Luteolin ameliorates experimental colitis in mice through ERK-mediated suppression of inflammation, apoptosis and autophagy
Iva Vukelić, Dijana Detel, Lara Batičić, et al.
Food and Chemical Toxicology (2020) Vol. 145, pp. 111680-111680
Closed Access | Times Cited: 53
Interventions of natural and synthetic agents in inflammatory bowel disease, modulation of nitric oxide pathways
Aida Kamalian, Masoud Sohrabi Asl, Mahsa Dolatshahi, et al.
World Journal of Gastroenterology (2020) Vol. 26, Iss. 24, pp. 3365-3400
Open Access | Times Cited: 51
Reparative Effects of Ethanol-Induced Intestinal Barrier Injury by Flavonoid Luteolin via MAPK/NF-κB/MLCK and Nrf2 Signaling Pathways
Jinwen Yuan, Siyan Che, Li Zhang, et al.
Journal of Agricultural and Food Chemistry (2021) Vol. 69, Iss. 14, pp. 4101-4110
Closed Access | Times Cited: 46
Effects of Medicinal Plants and Phytochemicals in Nrf2 Pathways during Inflammatory Bowel Diseases and Related Colorectal Cancer: A Comprehensive Review
Lucas Fornari Laurindo, Mariana Canevari de Maio, Giulia Minniti, et al.
Metabolites (2023) Vol. 13, Iss. 2, pp. 243-243
Open Access | Times Cited: 21
Comprehensive and critical view on the anti-inflammatory and immunomodulatory role of natural phenolic antioxidants
Aurelia Magdalena Pisoschi, Florin Iordache, Loredana Stanca, et al.
European Journal of Medicinal Chemistry (2023) Vol. 265, pp. 116075-116075
Closed Access | Times Cited: 17
Copper–luteolin nanocomplexes for Mediating multifaceted regulation of oxidative stress, intestinal barrier, and gut microbiota in inflammatory bowel disease
Wanyue Fu, Zhongshi Huang, Weiqi Li, et al.
Bioactive Materials (2024) Vol. 46, pp. 118-133
Open Access | Times Cited: 6
Luteolin‐mediated Kim‐1/NF‐kB/Nrf2 signaling pathways protects sodium fluoride‐induced hypertension and cardiovascular complications
Ademola Adetokunbo Oyagbemi, Temidayo Olutayo Omóbòwálé, Olufunke Eunice Ola‐Davies, et al.
BioFactors (2018) Vol. 44, Iss. 6, pp. 518-531
Closed Access | Times Cited: 56
Page 1 - Next Page

Scroll to top